Cargando…
999. Nasal Mucosal Cytokines: Potential Biomarkers for Pediatric Pneumonia Severity and Etiology
BACKGROUND: Community acquired pneumonia (CAP) is a leading cause of mortality in children < 5 years, but our understanding of disease pathogenesis remains limited. The objective of this study was to define the local host immune response in the respiratory tract by measuring nasal mucosal cytokin...
Autores principales: | Sayegh, Rouba, Yun, Ki Wook, Xu, Zhaohui, Wallihan, Rebecca, Marzec, Sarah, Leber, Amy, Everhart, Kathy, Cohen, Daniel M, Desai, Ankita P, Alter, Sherman J, Ambroggio, Lilliam, Florin, Todd A, Keaton, Meghan, Mertz, Sara, Shah, Samir S, Ruddy, Richard, Jones, Desiree, El-assal, Osama, Mejias, Asuncion, Ramilo, Octavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644307/ http://dx.doi.org/10.1093/ofid/ofab466.1193 |
Ejemplares similares
-
261. Alternative Antibiotic Prescribing for Community Acquired Pneumonia (CAP) in Pediatric Patients in Relation to Allergy Status
por: Desai, Ankita, et al.
Publicado: (2018) -
2210. Nasopharyngeal Detection of Streptococcus pneumoniae and Clinical Disease Severity in Children with Community-Acquired Pneumonia (CAP)
por: Wook Yun, Ki, et al.
Publicado: (2019) -
2619. Clinical Characteristics and Etiology of Community-Acquired Pneumonia in Children: A Contemporary, Prospective, Multicenter Study in Ohio, 2015–2018
por: Yun, Ki Wook, et al.
Publicado: (2019) -
Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
por: Quintero, Ana Maria, et al.
Publicado: (2022) -
204. Mucosal Cytokine Profiles in Children with COVID-19
por: Cohen, Shira H, et al.
Publicado: (2021)